FTRE vs. RDNT, GH, VCYT, VRDN, EXAS, NTRA, XENE, JANX, SWTX, and SGRY
Should you be buying Fortrea stock or one of its competitors? The main competitors of Fortrea include RadNet (RDNT), Guardant Health (GH), Veracyte (VCYT), Viridian Therapeutics (VRDN), Exact Sciences (EXAS), Natera (NTRA), Xenon Pharmaceuticals (XENE), Janux Therapeutics (JANX), SpringWorks Therapeutics (SWTX), and Surgery Partners (SGRY). These companies are all part of the "medical" sector.
RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
77.9% of RadNet shares are owned by institutional investors. 4.4% of RadNet shares are owned by company insiders. Comparatively, 0.1% of Fortrea shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
RadNet received 334 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.70% of users gave RadNet an outperform vote while only 38.46% of users gave Fortrea an outperform vote.
RadNet has higher earnings, but lower revenue than Fortrea.
RadNet presently has a consensus price target of $53.67, indicating a potential upside of 6.27%. Fortrea has a consensus price target of $37.29, indicating a potential upside of 3.51%. Given Fortrea's stronger consensus rating and higher possible upside, equities analysts clearly believe RadNet is more favorable than Fortrea.
RadNet has a net margin of 0.19% compared to RadNet's net margin of 0.00%. Fortrea's return on equity of 4.72% beat RadNet's return on equity.
In the previous week, Fortrea had 2 more articles in the media than RadNet. MarketBeat recorded 8 mentions for Fortrea and 6 mentions for RadNet. RadNet's average media sentiment score of 1.13 beat Fortrea's score of 0.51 indicating that Fortrea is being referred to more favorably in the news media.
Summary
RadNet beats Fortrea on 11 of the 15 factors compared between the two stocks.
Get Fortrea News Delivered to You Automatically
Sign up to receive the latest news and ratings for FTRE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding FTRE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
